Category: wiley retractions

“Strange. Very strange:” Retracted nutrition study reappears in new journal

In an unusual turn of events, a nutrition paper has come back to life a year after being pulled from its original publication.

After the paper was retracted from the journal Obesity, the authors revised it and republished it in another journal, Pediatric Obesity. Both journals are published by Wiley. The second version of the paper doesn’t mention the previous retraction. Indeed, the journal editor told us he didn’t know the paper had been retracted. Still, he stood by his decision to publish it.

The authors told us the paper was retracted after editors at Obesity raised concerns over the authors’ methodology. The authors revised the paper, adding some analysis and explanation of their methodological approach, and said the new version was accepted by peer reviewers before being published in Pediatric Obesity.

However, an outside expert who reviewed both papers for us said he thinks the authors didn’t change enough. According to Patrick McKnight, head of the Measurement, Research methodology, Evaluation, and Statistics group at George Mason University and a Statistical Advisory Board member of STATS.org:

Continue reading “Strange. Very strange:” Retracted nutrition study reappears in new journal

Nightmare scenario: Text stolen from manuscript during review

A food science journal has retracted a paper over “a breach of reviewer confidentiality,” after editors learned it contained text from an unpublished manuscript — which one of the authors appears to have reviewed for another journal.

The publisher and editors-in-chief of the Journal of Food Process Engineering became aware of the breach when the author of the unpublished manuscript lodged a complaint that his paper, under review at another journal, had been plagiarized by the now retracted paper.

We’re hazy on a few details in this case. Although the journal editor told us the “main author” of the retracted paper reviewed the original manuscript for another journal, the corresponding author of the retracted paper said he was not to blame. (More on that below.)

When looking into the matter, the publisher found that one of the co-authors of the published paper had acted as a reviewer of the unpublished manuscript. Alexandra Cury, an associate editor at Wiley, explained: Continue reading Nightmare scenario: Text stolen from manuscript during review

Prominent NIH researcher up to a dozen retractions

Stanley Rapoport. Source: NIH

Neuroscientist Stanley Rapoport hasn’t had much luck with his co-authors.

Recently, we’ve reported on multiple retractions of papers co-authored by Rapoport after three different first authors were found to have committed misconduct. Now, the fallout from one of those cases had led to four more retractions, bringing Rapoport’s total to 12.

The latest batch of retractions stem from the actions of Jagadeesh Rao.

Here’s the first notice, issued by Psychopharmacology:

Continue reading Prominent NIH researcher up to a dozen retractions

Paper quickly retracted after author used another group’s work

The author of a 2016 paper has agreed to retract it after an investigation revealed that most of the article came from another research group at the same university.

According to the notice, the author based the majority of his paper on results generated by other scientists without their permission.

Here’s the retraction notice for “Controlled synthesis of magnetic block copolymers for anti-microbial purpose,” published in the Journal of Applied Polymer Science in November and retracted in February: Continue reading Paper quickly retracted after author used another group’s work

Does a paywall protect patient privacy?

A psychoanalyst has retracted an award-winning 2016 paper over concerns that it contained “sensitive” patient information.

On July 15, Judith L. Mitrani, a psychoanalyst based in California, published an article that included “sensitive clinical material” about a patient. Although we do not know what prompted the concerns, on November 21, Mitrani, in agreement with the journal’s editor-in-chief and publisher, retracted the article. The author and editor told us the retraction was meant to prevent non-experts from accessing the paper and to stop other non-Wiley sites from posting it.

The article was published after it had won the journal’s essay contest in 2015.

Here’s the retraction notice for “On Separating One from the Other: Images of a Developing Self,” published in the British Journal of Psychotherapy (BJP):

Continue reading Does a paywall protect patient privacy?

Dangerous chemo mistake retracted by journal after two years

An oncology journal has retracted a 2014 paper that contained a potentially fatal mistake.

Specifically, the paper suggested that a chemotherapy drug be injected intrathecally — i.e., in the spine. But according to the retraction notice, the medical literature has unequivocally shown that that form of treatment is “uniformly fatal.”

The retraction comes approximately 18 months after the journal published a letter to the editor alerting readers to the risky wording in the 2014 paper.

Here’s the notice, issued by Hematological Oncology:

Continue reading Dangerous chemo mistake retracted by journal after two years

What turned a cancer researcher into a literature watchdog?

Jennifer Byrne

Sometime in the middle of 2015, Jennifer Byrne, professor of molecular oncology at the University of Sydney, began her journey from cancer researcher to a scientific literature sleuth, seeking out potentially problematic papers.

The first step was when she noticed several papers that contained a mistake in a DNA construct which, she believed, meant the papers were not testing the gene in question, associated with multiple cancer types.  She started a writing campaign to the journal editors and researchers, with mixed success. But less than two years later, two of the five papers she flagged have already been retracted.

When asked why she spent time away from bench research to examine this issue, Byrne told us:  Continue reading What turned a cancer researcher into a literature watchdog?

Authors retract tanning-UV radiation study for lacking approval

Researchers have agreed to pull a 2015 study exploring whether a plant extract can safeguard tanners from ultraviolet exposure after not obtaining formal approval from an ethics committee.

According to the first author, the problem lay in a misunderstanding – when they originally applied for approval six years ago, the researchers believed they didn’t need to go through a formal approval process, since the compound was commercially available without a prescription. Once they realized their mistake, they chose to retract the paper.

Here’s the retraction note for “Oral Polypodium leucomotos increases the anti-inflammatory and melanogenic responses of the skin to different modalities of sun exposures: a pilot study,” published in Photodermatology Photoimmunology & Photomedicine.  Continue reading Authors retract tanning-UV radiation study for lacking approval

A first for us: Journal retracts obituary (but not for the reasons you think)

journalofdigestivediseasesOn December 31st 2014, a pioneer in the study of inflammatory bowel disease passed away. An obituary published in the Journal of Digestive Diseases shortly thereafter is typical enough: It describes his achievements, importance to his patients, and battle with pancreatic cancer.

But “Loss in the Last Day of 2014: a Eulogy for Prof. Bing Xia” has now been retracted.

This is the first time we’ve seen an obituary pulled from a journal. Unfortunately, this was not a case of a premature obituary (which happens more often than you’d think)– the researcher did actually die, but it appears the journal published the obituary in the wrong place.

The retraction notice, published earlier this year, explains:

Continue reading A first for us: Journal retracts obituary (but not for the reasons you think)

Materials researcher falsified data in two studies, probe reveals

advanced-materialsA materials journal has retracted two 2013 papers, citing an investigation at Pennsylvania State University that concluded the first author falsified data.

According to the retraction notice in Advanced Materials, Mehdi Ghaffari — formerly based at Penn State — was solely responsible for the misconduct. Ghaffari’s LinkedIn page says he finished his PhD at Penn State in 2014, and now works as an independent consultant in New York, after a stint as a postdoc at Procter and Gamble.

A Penn State spokesperson sent us this statement:  Continue reading Materials researcher falsified data in two studies, probe reveals